Multiple Myeloma Research Consortium and Mount Sinai School of Medicine Announce Research Collaboration
Norwalk, CT & New York, NY--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) and Mount Sinai School of Medicine today announced that Mount Sinai has become the newest Member Institution to join the MMRC to accelerate the development of new treatments for multiple myeloma.